2KVE

C-terminal domain of mesencephalic astrocyte-derived neurotrophic factor (MANF)

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
2	2D 1H-13C HSQC	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
3	2D 1H-13C-CT-HSQC	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
4	3D CBCA(CO)NH	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
5	3D HNCACB	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
6	3D C(CO)NH	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
7	3D H(CCO)NH	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
8	2D (HB)CB(CGCD)HD	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
9	2D (HB)CB(CGCDCE)HE	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
10	3D 1H-15N NOESY	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298
11	3D 1H-13C NOESY	1mM [U-99% 13C; U-99% 15N] C-MANF; 93% H2O/7% D2O	93% H2O/7% D2O	50	6.5	AMBIENT	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY INOVA	600
2	Varian	UNITY INOVA	800

NMR Refinement
Method	Details	Software
TORSION ANGLE DYNAMICS, simulated annealing, TORSION ANGLE DYNAMICS		CYANA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	400
Conformers Submitted Total Number	15
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	automated noe assignment	CYANA	2.0.26	P.GUNTERT ET AL.
2	structure solution	Amber	8.0	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollm
3	refinement	Amber	8.0	Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, and Kollm

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.